DRGEM Financial Statements From 2010 to 2024

263690 Stock  KRW 6,390  140.00  2.14%   
DRGEM financial statements provide useful quarterly and yearly information to potential DRGEM investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on DRGEM financial statements helps investors assess DRGEM's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting DRGEM's valuation are summarized below:
DRGEM does not today have any fundamental signals for analysis.
Check DRGEM financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DRGEM's main balance sheet or income statement drivers, such as , as well as many indicators such as . DRGEM financial statements analysis is a perfect complement when working with DRGEM Valuation or Volatility modules.
  
This module can also supplement various DRGEM Technical models . Check out the analysis of DRGEM Correlation against competitors.

DRGEM Company Current Valuation Analysis

DRGEM's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current DRGEM Current Valuation

    
  128.76 B  
Most of DRGEM's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DRGEM is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, DRGEM has a Current Valuation of 128.76 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Health Care Equipment & Supplies industry. The current valuation for all Republic of Korea stocks is significantly lower than that of the firm.

DRGEM Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining DRGEM's current stock value. Our valuation model uses many indicators to compare DRGEM value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DRGEM competition to find correlations between indicators driving DRGEM's intrinsic value. More Info.
DRGEM is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.01  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for DRGEM is roughly  155.96 . Comparative valuation analysis is a catch-all model that can be used if you cannot value DRGEM by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DRGEM's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About DRGEM Financial Statements

DRGEM stakeholders use historical fundamental indicators, such as DRGEM's revenue or net income, to determine how well the company is positioned to perform in the future. Although DRGEM investors may analyze each financial statement separately, they are all interrelated. For example, changes in DRGEM's assets and liabilities are reflected in the revenues and expenses on DRGEM's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in DRGEM. Please read more on our technical analysis and fundamental analysis pages.
DRGEM Corporation manufactures and sells diagnostic radiography systems worldwide. It offers high frequency X-ray generators, and conventional and digital radiography systems. DRGEM is traded on Korean Securities Dealers Automated Quotations in South Korea.

Pair Trading with DRGEM

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DRGEM position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DRGEM will appreciate offsetting losses from the drop in the long position's value.

Moving together with DRGEM Stock

  0.7228670 Ray CoPairCorr
  0.84950130 Access BioPairCorr

Moving against DRGEM Stock

  0.65105560 KB Financial GroupPairCorr
The ability to find closely correlated positions to DRGEM could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DRGEM when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DRGEM - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DRGEM to buy it.
The correlation of DRGEM is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DRGEM moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DRGEM moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DRGEM can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in DRGEM Stock

DRGEM financial ratios help investors to determine whether DRGEM Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DRGEM with respect to the benefits of owning DRGEM security.